Vasodilators: Ergoloid mesylates & Isoxsuprine
Limited clinical evidence to support the efficacy in treating dementia or Alzheimer’s Disease.
Avoid in patients with late-stage dementia.
- Exploring the enablers and barriers to implementing the Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) criteria in Australia: a qualitative study
- “Prescriber’s Drug Reference. (2019). Ergoloid mesylates–drug summary. https://www.pdr.net/drug-summary/Ergoloid-Mesylates-ergoloid-mesylates-735
- Chemical datasheet: Hydergine
- NIH US National Library of Medicine: Daily Med. (2018). Label: Isoxsuprine hydrochloride.